Carregant...
Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive disease with poor outcomes in patients ineligible for autologous stem cell transplantation. In this setting, novel treatment approaches are urgently required and the innovative agent pixantrone has shown some promising res...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039066/ https://ncbi.nlm.nih.gov/pubmed/32194699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11288 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|